NCT07548450 clinical trial report covering Mosunetuzumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07548047 clinical trial report covering Dextrose, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07547436 clinical trial report covering SAR-445399, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07546812 clinical trial report covering Denikitug, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07547995 clinical trial report covering Genakumab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07549646 clinical trial report covering Trametinib dimethyl sulfoxide, Phase 2, endpoints, sponsor, geography, readout timing and development white spac

NCT07549906 clinical trial report covering Iparomlimab/Tuvonralimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

CTR20261222 clinical trial report covering XiaoErFeiReKeChuan, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07550881 clinical trial report covering Dexmedetomidine Hydrochloride, Phase 2, endpoints, sponsor, geography, readout timing and development white spac

ChiCTR2600123343 clinical trial report covering Oxaliplatin, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07550920 clinical trial report covering Retlirafusp alfa, Phase 2, endpoints, sponsor, geography, readout timing and development white space.

NCT07550088 clinical trial report covering Botensilimab, Phase 2, endpoints, sponsor, geography, readout timing and development white space.